Proactive tongue-strengthening after partial/hemiglossectomy with reconstruction
Official title: Impact of Tongue Proactive Strengthening Exercise Program on Speech and Swallowing Outcomes Following Partial/Hemiglossectomy and Reconstruction
Run by Case Comprehensive Cancer Center · NCT07110142 · Data updated 2026-11-12
This program tests whether adding a proactive tongue-strengthening exercise using a Tongueometer biofeedback device helps adults who undergo partial or hemi-glossectomy with reconstruction improve speech and swallowing.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Case Comprehensive Cancer Center Academic / other |
| Drugs / interventions | radiation, chemotherapy |
| Locations | 1 site (Cleveland, Ohio) |
| Status | Recruiting |
| Started | December 10, 2025 |
| Main results expected | June 2028 |
| Study ends | June 2029 |
| Registry record updated | August 6, 2026 |
| Trial ID | NCT07110142 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 or older undergoing resection of ≤50% of the native tongue (partial or hemiglossectomy) with immediate reconstruction who have no prior head and neck cancer or radiation and can complete study questionnaires in English, French, Spanish, or Simplified Chinese.
✕Probably not a fit
Patients with distant metastases, prior head and neck radiation, prior speech-language treatment for non-head-and-neck causes, or those requiring mandibulectomy or >50% tongue resection are excluded and unlikely to receive benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study introduces a structured, proactive tongue-strengthening exercise program using a Tongueometer biofeedback device for patients undergoing partial or hemiglossectomy with immediate reconstruction. Participants receive the exercise program early after surgery in addition to usual postoperative care, and speech and swallowing outcomes are tracked over time using validated questionnaires and functional measures. The trial compares outcomes from the proactive program to standard symptom-driven therapy to see if earlier, device-guided strengthening yields better long-term function. Eligible adults must have ≤50% native tongue resection, no prior head and neck cancer or radiation, and be able to complete questionnaires in English, French, Spanish, or Simplified Chinese.
Why it matters
Potential benefit: If successful, this approach could improve recovery of speech and swallowing and be added to standard post-operative care.
How similar studies have gone: Previous small studies of tongue-strengthening exercises and biofeedback devices have reported improvements in tongue strength and some swallow outcomes, but evidence is limited and using a proactive post-operative program after glossectomy is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. ≥18 years of age 2. No prior history of head and neck cancer 3. No prior history of radiation 4. Planned to undergo resection of ≤50% of the native tongue (partial/hemiglossectomy) with immediate reconstruction, including free flap reconstruction, and with or without neck dissection 5. Sufficiently fluent in written English, French, Spanish or Simplified Chinese to complete the study outcomes questionnaires Exclusion Criteria: 1. Distant metastasis at enrollment 2. Previously seen and treated by speech and language pathologist for dysphagia or dysarthria for non-head and neck cancer causes 3. Prior head and neck radiation 4. Requires mandibulectomy or \>50% resection of native tongue
Where it's running
-
Case Comprehensive Cancer Center, Cleveland Clinic Foundation
Cleveland, Ohio, United States Recruiting
Study contacts
- Principal investigator: Jamie Ku, MD, FACS — Case Comprehensive Cancer Center, Cleveland Clinic
- Study coordinator: Jamie Ku, MD, FACS
- Email: kuj@ccf.org
- Phone: (216) 445-6594
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Monitoring circulating tumor cells in postoperative ENE-positive oral cavity cancer after adjuvant concurrent chemoradiation.
This trial will test whether regular blood monitoring of circulating tumor cells and adding extended low-dose oral chemotherapy can help people with ENE-positive oral cavity squamous cell carcinoma after surgery and adjuvant concurrent chemoradiation.
-
Using brodalumab to treat immune-related side effects from cancer therapy
This study is testing if brodalumab can help cancer patients who are having immune-related side effects from their immunotherapy treatment feel better.
-
Pre-surgery metronidazole and chlorhexidine to lower bacteria in oral cavity tumors
This study will try a short course of the antibiotic metronidazole plus chlorhexidine mouthwash before surgery to see if it lowers bacteria inside tumors in adults with oral squamous cell carcinoma.
-
Investigating the role of microbiome in head and neck cancer
This study is trying to see if changes in the bacteria in the mouth are linked to head and neck cancer by comparing patients with the cancer to people without it.
-
Phenotype-based Pain Guidance for Head and Neck Cancer-Related Pain (pilot)
This pilot test sees if tailoring pain treatment to a patient’s pain type can reduce head and neck cancer pain in adults who haven’t started cancer treatment yet.
-
Airway ultrasound in head and neck cancer patients
This observational study tests whether neck ultrasound measurements of the airway match CT measurements in adults with maxillofacial cancer undergoing surgery with anesthesia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.